{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Digestion", "Enzyme inhibition", "Hydrolases", "Phytotherapy", "Polyphenols"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37399788", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1159/000531745"], "Journal": {"ISSN": "2504-2106", "JournalIssue": {"Volume": "30", "Issue": "5", "PubDate": {"Year": "2023"}}, "Title": "Complementary medicine research", "ISOAbbreviation": "Complement Med Res"}, "ArticleTitle": "Plant Polyphenols as Inhibitors of Hydrolases are Regulators of Digestion.", "Pagination": {"StartPage": "453", "EndPage": "459", "MedlinePgn": "453-459"}, "Abstract": {"AbstractText": ["There are numerous reports on the use of polyphenol-containing foods and various medicinal plant preparations for the prophylaxis and therapy of metabolic diseases, such as metabolic syndrome and diabetes mellitus, respectively. One unifying aspect to the effect of these natural compounds is their ability to inhibit digestive enzymes, which is the focus of this review.", "Polyphenols inhibit nonspecifically hydrolytic enzymes included in the digestion process, e.g., amylases, proteases, lipases. By that, the digestion process is protracted with different consequences as result of the incomplete absorption of monosaccharides, fatty acids, and amino acids as well as for the enhanced availability of substrates for the microbiome in ileum and colon. The resulting postprandial blood concentration of monosaccharides, fatty, and amino acids is lowered and by that different metabolic pathways proceed more slowly. As another positive result, polyphenols can also modulate the intestinal microbiome and thus mediate additional beneficial health effects.", "Many medicinal plants possess a broad spectrum of different polyphenols, thereby mediating the nonspecific inhibition of all hydrolytic enzyme activities in the gastrointestinal digestive process. As a consequence of the slowing down of digestive processes, risk factors for the development of metabolic disorders are reduced and the health of the patients with metabolic syndrome improves.", "<title>Hintergrund</title>Es gibt zahlreiche Berichte \u00fcber die Verwendung von polyphenolhaltigen Lebensmitteln und verschiedenen Arzneilpflanzenpr\u00e4paraten zur Prophylaxe und Therapie von Stoffwechselkrankheiten wie dem metabolischen Syndrom und Diabetes mellitus. Ein \u00fcbergreifender Aspekt der Wirkung dieser Naturstoffe ist ihre F\u00e4higkeit, Verdauungsenzyme zu hemmen, was im Mittelpunkt dieser \u00dcbersicht steht.<title>Zusammenfassung</title>Polyphenole hemmen unspezifisch hydrolytische Enzyme, die am Verdauungsprozess beteiligt sind, z.B. Amylasen, Proteasen, Lipasen. Dadurch wird der Verdauungsprozess verz\u00f6gert, was sich in einer unvollst\u00e4ndigen Resorption von Monosacchariden, Fetts\u00e4uren und Aminos\u00e4uren sowie in einer erh\u00f6hten Verf\u00fcgbarkeit von Substraten f\u00fcr das Mikrobiom im Ileum und Kolon \u00e4u\u00dfert. Dadurch wird die postprandiale Blutkonzentration von Monosacchariden, Fetts\u00e4uren und Aminos\u00e4uren gesenkt und verschiedene Stoffwechselwege laufen langsamer ab. Ein weiteres positives Ergebnis ist, dass Polyphenole auch das intestinale Mikrobiom modulieren k\u00f6nnen und damit zus\u00e4tzliche positive Gesundheitseffekte vermitteln.<title>Kernaussagen</title>Viele Arzneipflanzen verf\u00fcgen \u00fcber ein breites Spektrum verschiedener Polyphenole, die eine unspezifische Hemmung aller hydrolytischen Enzymaktivit\u00e4ten im gastrointestinalen Verdauungsprozess bewirken. Durch die Verlangsamung der Verdauungsprozesse werden Risikofaktoren f\u00fcr die Entwicklung von Stoffwechselst\u00f6rungen reduziert und der Gesundheitszustand von Patienten mit metabolischem Syndrom verbessert."], "CopyrightInformation": "\u00a9 2023 S. Karger AG, Basel."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Freie Universitaet Berlin, Institute of Pharmacy, Berlin, Germany."}], "LastName": "Melzig", "ForeName": "Matthias F", "Initials": "MF"}], "PublicationTypeList": ["Journal Article", "Review"], "VernacularTitle": "Pflanzliche Polyphenole als Inhibitoren von Hydrolasen sind Regulatoren der Verdauung."}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Complement Med Res", "NlmUniqueID": "101698453", "ISSNLinking": "2504-2092"}, "ChemicalList": [{"RegistryNumber": "EC 3.-", "NameOfSubstance": "Hydrolases"}, {"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Monosaccharides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hydrolases"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Metabolic Syndrome"}, {"QualifierName": [], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Amino Acids"}, {"QualifierName": [], "DescriptorName": "Monosaccharides"}, {"QualifierName": [], "DescriptorName": "Digestion"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2023", "Month": "2", "Day": "10"}, {"Year": "2023", "Month": "6", "Day": "23"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "4", "Hour": "1", "Minute": "5"}, {"Year": "2023", "Month": "7", "Day": "3", "Hour": "18", "Minute": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37399788", "10.1159/000531745", "000531745"]}}], "PubmedBookArticle": []}